A once-daily treatment designed with comfort in mind
*Based on Monthly Prescription Data, February 2021
*Individual results may vary
PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in patients after cataract surgery.
Please click here for full Prescribing Information for PROLENSA®.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call1-800-FDA-1088.